Actinium Pharmaceuticals Inc (ATNM)

02:06 AM

Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030 - GlobeNewswire Inc.

02:06 AM

01:28 AM

Is Actinium Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com

01:28 AM

Oct 15, 2025

What high frequency data says about Actinium Pharmaceuticals Inc.2025 Top Decliners & Technical Entry and Exit Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals - TipRanks

Oct 15, 2025

Oct 15, 2025

Can Actinium Pharmaceuticals Inc. recover in the next quarterJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com

Oct 15, 2025

Oct 13, 2025

Actinium Pharmaceuticals (ATNM) Reveals Promising Data for NSCLC Treatment - GuruFocus

Oct 13, 2025

Oct 13, 2025

Actinium Shares Rise After Preclinical Data for ATNM-400 Show Potent Anti-Tumor Activity in Lung Cancer Models - MarketScreener

Oct 13, 2025

Oct 13, 2025

Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire

Oct 13, 2025

Oct 13, 2025

Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - Eastern Progress

Oct 13, 2025

Oct 12, 2025

Is Actinium Pharmaceuticals Inc. (Delaware) stock a contrarian opportunityMarket Risk Report & AI Powered Market Trend Analysis - newser.com

Oct 12, 2025

Oct 10, 2025

Why Actinium Pharmaceuticals Inc. (7AY1) stock remains stableWeekly Trading Summary & Verified Momentum Watchlists - newser.com

Oct 10, 2025

Oct 10, 2025

Will Actinium Pharmaceuticals Inc. (Delaware) stock beat international competitionInflation Watch & AI Forecasted Stock Moves - newser.com

Oct 10, 2025

Oct 09, 2025

How geopolitical risks impact Actinium Pharmaceuticals Inc. (7AY1) stockSell Signal & High Return Stock Watch Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Exit strategy if you’re trapped in Actinium Pharmaceuticals Inc.Market Weekly Review & High Conviction Buy Zone Picks - newser.com

Oct 09, 2025

Oct 06, 2025

Will Actinium Pharmaceuticals Inc. stock remain a Wall Street favoritePrice Action & Real-Time Volume Trigger Notifications - newser.com

Oct 06, 2025

Oct 06, 2025

Will Actinium Pharmaceuticals Inc. stock recover faster than marketJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com

Oct 06, 2025

Oct 06, 2025

Short interest data insights for Actinium Pharmaceuticals Inc.IPO Watch & Risk Managed Investment Signals - newser.com

Oct 06, 2025

Oct 06, 2025

Does Actinium Pharmaceuticals Inc. show high probability of rebound2025 Historical Comparison & Risk Managed Trade Strategies - newser.com

Oct 06, 2025

Oct 05, 2025

How big funds are accumulating Actinium Pharmaceuticals Inc. (7AY1) stockQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com

Oct 05, 2025

Oct 05, 2025

How Actinium Pharmaceuticals Inc. (7AY1) stock performs in volatility spikesRate Cut & Real-Time Volume Analysis - newser.com

Oct 05, 2025

Oct 05, 2025

Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com

Oct 05, 2025

Oct 03, 2025

Actinium Pharmaceuticals Inc. stock trend forecast2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com

Oct 03, 2025

Oct 02, 2025

How to use Fibonacci retracement on Actinium Pharmaceuticals Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com

Oct 02, 2025

Oct 01, 2025

Published on: 2025-10-01 07:40:56 - newser.com

Oct 01, 2025